Immunogen (IMGN) Posts Q4 Loss of 71c/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/8/2026
- Wall St futures slide as rising oil, yields dampen mood
- Oil jumps as Middle East supply concerns persist amid shipping attacks
- Want to be a stock market bear? BCA says watch potential U.S. tax increases
- SpaceX seeks $40bn in financing for Nvidia chip purchase
- Chip stock could soar nearly 200%, analyst says: "If you don’t buy it, they will"
- Anthropic launches Claude Haiku 5.5 with tiered pricing structure
- Sportradar to sell Synergy Sports coaching unit for $170M
- Rezolve AI (RZLV) Reiterated at Overweight by Cantor Fitzgerald on Positioning as Key Component in E-Commerce Stack
- Wall Street ends lower, off record highs, as Treasury yields climb
- Applied Digital (APLD) Tops Q1 EPS by 26c, Beats on Revenue
Cantor Fitzgerald Downgrades Immunogen Inc. (IMGN) to Hold
August 3, 2015 6:43 AM EDTCantor Fitzgerald downgraded Immunogen Inc. (NASDAQ: IMGN) from Buy to Hold with a price target of $21.00 (from $12.00) on valuation.
Analyst Mara Goldstein commented, "We are downgrading ImmunoGen shares to HOLD from BUY, and raising our PT to $21 from $12. Our PT raise reflects... More
Immunogen (IMGN) PT Raised to $24 at Oppenheimer Ahead of '853 Path Forward
July 29, 2015 8:33 AM EDTOppenheimer analyst Christopher Marai reiterated an Outperform rating and raised his price target on Immunogen Inc. (NASDAQ: IMGN) to $24.00 (from $13.00) in anticipation of clarity on '853's path forward and updated data by
YE15. We also anticipate these updates, potentially on Friday's... More



